Perirenal Edema as a potential hint towards primary hypertension—Preliminary findings in MRI breast cancer staging  by Kaiser, Clemens G. et al.
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Purpose:  To  demonstrate  our  primary  ﬁndings,  indicating  perirenal  edema  as  a ﬁrst  imaging  sign towards
primary  hypertension.
Methods: Out  of 3190  consecutive  MR-Mammography  (MRM)  examinations,  777 were  performed  with
an additional  body  array coil.  Incidentally,  “perirenal  edema”  could  be  linked  to  a patient  history  of
hypertension.  We  Therefore  speciﬁcally  further  observed  the correlation.
Results:  Of 777  patients  86  (11%)  patients  showed  the  perirenal  edema  sign  (PES).  Upon  inquiry  all  of
these  cases  (100%)  conﬁrmed  a  past  or present  history  of  hypertensive  disease  (i.e. blood  pressure  above
140/90  and/or  anti-hypertensive  treatment).
Conclusion:  Our  preliminary  results  strongly  indicate  a strong  correlation  between  perirenal  edema  and
primary hypertension.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
MR-Mammography (MRM)  or dynamic enhanced Breast-MRI
DCE-MRI) has evolved to be increasingly important over the last
0 years. However, the main breast imaging societies are hesitant
o support MRM  as a screening tool [1]. Guidelines of the Ameri-
an college of radiology (ACR), European Society of Breast Imaging
EUSOBI) as well as well as European Society of Breast Cancer Spe-
ialists (EUSOMA) list among the speciﬁc indications for breast MRI
ainly patients after operation or radiation of breast cancer, pre-
perative staging, cancer of unknown primary (CUP Syndrome) and
 genetic disposition (e.g. BRCA1 or 2) [2–5].
In our university hospital a body array coil is placed onto theack of patients in order to cover the upper half of the body from
he neck to the upper lumbar region (Fig. 1) in case of a history
f previous cancer or the new detection of a malignant lesion in
∗ Corresponding author at: University Medical Centre Mannheim, Medical
aculty Mannheim—University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167
annheim, Germany.
E-mail address: clemens.kaiser@umm.de (C.G. Kaiser).
Fig. 1. Breast and half-body examination in one exam. The body array coil is placed
on the back of the patient while being positioned on the breast coil for the exami-
nation in a supine position.
ttp://dx.doi.org/10.1016/j.ejro.2016.05.004
352-0477/© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
.0/).
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rder to simultaneously gather staging information. By an inci-
ental ﬁnding, some patients would show diffuse perirenal edema
round both kidneys in those T2-weighted TSE images, acquired
Fig. 2). Upon inquiry, patients conﬁrmed history of hypertension.
hese incidental ﬁndings initiated a speciﬁc observation with the
im to address the question as to how often this new sign is asso-
iated with a hypertensive anamnesis and possibly to explain the
athophysiological background of the ﬁnding.
. Material and methods
.1. Patient collective
Between July 2010 and December 2012 a consecutive total
f 1975 MRM  examinations were performed with indications for
RM  as described above. All patients gave their written consent to
his IRB approved study.
376 of these examinations were performed including the addi-
ional positioning of a body array coil onto the back of the patient
ying in a prone position for their breast exam (Fig. 1). The main
ndication for this procedure was originally the search for metas-
ig. 2. 63y patient with a history of breast cancer. In the additionally acquired T2-TSE HAST
tains  around both kidneys) without any signs of renal parenchyma destruction or renal adiology Open 3 (2016) 123–126
tases in the upper spine, lung and liver for staging purposes. By
chance, perirenal edema were discovered, and deﬁned as high sig-
nal ﬂuid spatters and rims surrounding the renal capsule in the
perirenal fatty tissue around both kidneys (Fig. 2) in a thickness of
0.3–3.0 cm.
2.2. Image acquisition and interpretation
All MRM  exams were performed with a 1.5 Tesla-MR Scan-
ner (Siemens Avanto) using breast protocols as described in other
publications [6]. The body array coil along with the application of
an additional T2 weighted coronal TSE HASTE sequence in a slice
thickness of 5 mm covered the area from the neck to the upper
lumbar region, depending on the patients size (Table 1). The T2-
weighted HASTE-sequence was performed in a repetition Time (TR)
of 1100 ms,  an echo Time (TE) of 118 ms,  a ﬁeld-of-View (FOV)
of 500 mm in a parallel-imaging technique (PAT, GRAPPA) with
a PAT-factor of 2 in 46 coronal slices, resulting in a voxel size of
1.4 × 1.1 × 5 mm3. The total acquisition time of this “half-body”-
sequence was  51 s (Table 1). This protocol has been previously
described in [18,19]. MRI  examinations were evaluated by two
E sequence for staging purposes images display the PES (spotty, T2-TSE hyperintense
affection.
C.G. Kaiser et al. / European Journal of R
Table.  1
Examination protocol of the T2 weighted TSE HASTE sequence, which was  applied
whenever the patient had a history of previous breast cancer, surgery or present
breast cancer. The primary intention was the search for osseous metastasis in arms,
upper spine, lung and liver. The measurement time of this sequence is 51 s.
Sequence T2 TSE HASTE
Weighting T2
Puls sequence TSE
Orientation cor
TR (ms) 1100
TE (ms) 118
Flip angle (◦) 150
Slice thickness (mm)  5
Gap (mm)  0
Field of view (mm)  500
No. of slices 46
3
e
t
P
i
d
3
p
(
d
t
v
k
T
4
b
e
e
c
b
W
m
t
t
a
h
o
s
h
A
I
t
s
(
p
m
d
aVoxel 1,4 × 1,1 × 5 = 7,7 mm
xperienced radiologists (one with an experience of >15.000 cases,
he other with an experience of >1.000 cases in MRI). For a positive
ES, both readers had to agree on its presence. All patients show-
ng this sign were asked about their hypertensive history and other
iseases directly after the MR-examination.
. Results
Of 777 patients, examined with the body array coil, 86 (11%)
atients showed the “perirenal edema sign”. All of these patients
100%) conﬁrmed a present of a previous or present hypertensive
isease history (i.e. high blood pressure and/or antihypertensive
reatment). No patient reported deviant kidney disease in the pre-
ious history (e.g. kidney cancer or nephritis or any surgery of the
idneys). A simultaneous urinary tract infection could be excluded.
here was no false positive case, resulting in a PPV of 100%.
. Discussion
To this day, there have been numerous publications about whole
ody imaging in patients with breast cancer or other oncological
ntities, mainly with the purpose of improved staging [7].
However, the PES has not yet been reported in medical lit-
rature, especially concerning evidence of a histo-pathological
orrelation with this new diagnostic sign.
This seems somewhat surprising, since the number of whole-
ody MR-examinations has markedly increased in the last decades.
e are assuming, that most authors were primarily looking for
etastases.
The astonishing, however, preliminary result of this study was
he fact that there was no patient showing this sign without hyper-
ensive correlation (no “false positive” case). It can therefore be
ssumed, that there is a strong correlation between this sign and
ypertension. However, we have so far not evaluated false negative
r true negative cases, because only patients clearly showing this
ign have been correlated with the gold standard “past or present
igh blood pressure”.
A possible explanation for this new sign might be the effects of
ngiotensin II as an inﬂammatory mediator [8–10]. Angiotensin
I is produced locally in inﬂamed vessels and induces the syn-
hesis and secretion of interleukin-6, a cytokine that induces the
ynthesis of angiotensinogen in the liver through a janus kinase
JAK)/signal transducer and activator of transcription (STAT)-3
athway. Enhanced angiotensinogen production, in turn, supplies
ore substrate to the activated vascular RAS, where locally pro-
uced Angiotensin II synergizes with oxidized lipid to perpetuate
therosclerotic vascular inﬂammation [11]. Additionally, we knowadiology Open 3 (2016) 123–126 125
that blockage of the Angiotensinogen Receptor reduces a row of
inﬂammatory markers (CRP, TNF-, IL-6) [12].
As to what extent Angiotensin II could be responsible for
inﬂammatory processes strictly outside the renal capsule, however,
remains the effort of future studies.
Despite the role of Angiotensine II as the critical part in the
Renin-Angiotensinogen-Angiotensine-System (RAAS) we  know,
that it is produced following hypotension instead of hypertensive
changes, we saw in our patients.
According to Johnson et al. and Pauletto et al. [13,14], interest-
ingly the question remains as to whether hypertension is preceded
by inﬂammation or inﬂammation by hypertension.
On the one hand, hypertension acts as a major determinant of
endothelial dysfunction and vascular damage, promoting inﬂam-
matory activation of endothelial cells, recruitment of inﬂammatory
cells in the arterial wall and activation of vascular resident elements
[14].
On the other hand, vascular and inﬂammatory tubulo-
interstitial structural changes occurring in the kidneys have been
related to the pathogenesis of essential hypertension [13]. Evidence
obtained from animal models of spontaneously developed hyper-
tension showed that an inﬂammatory inﬁltration of the kidney by
macrophages and lymphocytes.
The renal tubule-interstitial inﬂammation is observed at a young
age in the animals and seems to precede the onset of hypertension
[15]. Recent studies in this animal model of hypertension showed
that the recruitment of immune cells in the kidney can be prevented
by blocking NF-B activation. This phenomenon is accompanied
by a complete abrogation of hypertension development in sponta-
neously hypertensive rats (SHR) [16].
Pauletto et al. assume, that even if the factors inducing the
inﬂammatory response in the kidney are not deﬁned, the inﬁl-
tration of immune cells and the oxidative stress in the renal
interstitium can play a pathogenic role in the future development
of hypertension. In case this phenomenon has some relevance in
humans it could be hypothesized that the low-grade inﬂammatory
status preceding hypertension development could mirror a silent
inﬂammatory damage occurring in the kidney [14].
It is important to notice, that all our “true-positive” patients did
not reveal any other morphologic signs of hypertension, as far as
detectable on the acquired T2-TSE-HASTE images, such as for exam-
ple adrenal tumors or vascular changes. Parenchymal renal defects,
i.e. purely renal causes, such as nephritis as cause for the PES could
also not be found in any of the cases.
Since this study has only offered a glimpse on how many cases
of perirenal edema could be correlated to hypertension, further
studies need to evaluate how many cases of hypertension can be
correlated with the sign.
As a limitation to our study, it has to be critically added, that
in our study the patients information about their hypertensive his-
tory was  only veriﬁed in direct interaction with the patients, i.e. no
additional measurement of the present blood pressure during or
after the MRM  examination was performed. Detailed information
about the extend of hypertension as well as theoretical relevance
for therapeutic consequences in hypertensive treatment are still a
matter of the future scientiﬁc evaluation.
However, the PES may be the ﬁrst diagnostic typical or maybe
even speciﬁc sign of primary hypertension, so far having been con-
sidered invisible to MRI-imaging. If these ﬁndings can be conﬁrmed
in further studies, the PES could be a strong, fast and robust indica-
tor with a high positive predictive value for primary hypertension.Conﬂict of interests
There are no conﬂicts of interest.
1 al of R
A
t
S
R
[
[
[
[
[
[
[
[
[
[19] P.A.T. Baltzer, M.  Dietzel, H.P. Burmeister, R. Zoubi, M.  Gajda, O. Camara, W.A.
Kaiser, Application of MR mammography beyond local staging: is there a26 C.G. Kaiser et al. / European Journ
cknowledgment
Published in part (lecture and abstract) during the “6th Interna-
ional Congress on MR-Mammography” in Jena, Germany (27.-29.
eptember 2012) [17].
eferences
[1] C.G. Kaiser, C. Reich, M. Dietzel, et al., DCE-MRI of the breast in a stand-alone
setting outside a complementary strategy – results of the TK-study, Eur.
Radiol. 25 (6) (2015) 1793–1800.
[2] E.S. Burnside, E.A. Sickles, L.W. Bassett, et al., The ACR BI-RADS® experience:
learning from history, J. Am.  Coll. Radiol. 6 (12) (2009) 851–860.
[3] S.D. Edwards, J.A. Lipson, D.M. Ikeda, J.M. Lee, Updates and revisions to the
BI-RADS magnetic resonance imaging lexicon, Magn. Reson. Imaging Clin. N.
Am.  21 (3) (2013) 483–493.
[4] R.M. Mann, C.K. Kuhl, K. Kinkel, C. Boetes, Breast MRI: guidelines from the
european society of Breast imaging, Eur. Radiol. 18 (7) (2008) 1307–1318.
[5] F. Sardanelli, C. Boetes, B. Borisch, et al., Magnetic resonance imaging of the
breast: recommendations from the EUSOMA working group, Eur. J. Cancer
Oxf. Engl. 46 (8) (2010) 1296–1316, 1990.
[6] C. Kuhl, The current status of breast MR imaging Part I. Choice of technique,
image interpretation, diagnostic accuracy, and transfer to clinical practice,
Radiology 244 (2) (2007) 356–378.
[7] G.P. Schmidt, A. Baur-Melnyk, R. Tiling, et al., Comparison of high resolution
whole-body MRI  using parallel imaging and PET-CT: First experiences with a
32-channel MRI  system, Radiologe 44 (9) (2004) 889–898.
[8] E.S. Androulakis, D. Tousoulis, N. Papageorgiou, et al., Essential hypertension:
is there a role for inﬂammatory mechanisms? Cardiol. Rev. 17 (5) (2009)
216–221.
[9] R. Toni, A. Malaguti, S. Castorina, E. Roti, R.M. Lechan, New paradigms in
neuroendocrinology: relationships between obesity, systemic inﬂammation
and the neuroendocrine system, J. Endocrinol. Invest. 27 (2) (2004) 182–186.adiology Open 3 (2016) 123–126
10] M.I. Phillips, S. Kagiyama, Angiotensin II as a pro-inﬂammatory mediator,
Curr. Opin. Investig. Drugs Lond. Engl. 3 (4) (2002) 569–577, 2000.
11] A.R. Brasier, A. Recinos 3rd, M.S. Eledrisi, Vascular inﬂammation and the
renin-angiotensin system, Arterioscler. Thromb. Vasc. Biol. 22 (8) (2002)
1257–1266.
12] B. López, R. Querejeta, N. Varo, et al., Usefulness of serum carboxy-terminal
propeptide of procollagen type I in assessment of the cardioreparative ability
of  antihypertensive treatment in hypertensive patients, Circulation 104 (3)
(2001) 286–291.
13] R.J. Johnson, B. Rodriguez-Iturbe, D.-H. Kang, D.I. Feig, J. Herrera-Acosta, A
unifying pathway for essential hypertension, Am. J. Hypertens. 18 (3) (2005)
431–440.
14] P. Pauletto, M.  Rattazzi, Inﬂammation and hypertension: the search for a link,
Nephrol. Dial. Transplant. 21 (4) (2006) 850–853.
15] B. Rodríguez-Iturbe, Y. Quiroz, A. Ferrebuz, G. Parra, N.D. Vaziri, Evolution of
renal interstitial inﬂammation and NF-kappaB activation in spontaneously
hypertensive rats, Am.  J. Nephrol. 24 (6) (2004) 587–594.
16] B. Rodríguez-Iturbe, A. Ferrebuz, V. Vanegas, et al., Early and sustained
inhibition of nuclear factor-kappaB prevents hypertension in spontaneously
hypertensive rats, J. Pharmacol. Exp. Ther. 315 (1) (2005) 51–57.
17] C.G. Kaiser, C. Reich, W.A. Kaiser, The ‘perirenal edema sign’ as a hint towards
hypertension–preliminary observations on coﬁndings in MRI breast cancer
staging, Eur. J. Radiol. 81 (Suppl. 1) (2012) S74–75.
18] M.  Dietzel, R. Zoubi, H.P. Burmeister, I.B. Runnebaum, W.A. Kaiser, P.A.T.
Baltzer, Combined staging at one stop using MR mammography: evaluation of
an  extended protocol to screen for distant metastasis in primary breast cancer
– initial results and diagnostic accuracy in a prospective study, Rofo 184
(2012) 618–623.potential to accurately assess axillary lymph nodes? evaluation of an
extended protocol in an initial prospective study, AJR Am.  J. Roentgenol. 196
(2011) W641–W647.
